Currently, the 750mcg teriparatide injection product is accessible in Australia despite this its supply is limited . Generally, it’s dispensed for patients with debilitating osteoporosis who display an inability to respond adequately to, or are unable tolerate, other therapies. Regarding pricing can vary significantly depending on a dispensing ch